FORA.tv Speaker - Martin LeBlanc
President and CEO Martin LeBlanc, of Caprion Proteomics, led the development and implementation of Caprion's proteomics technology when he co-founded the company. He also helped establish profitable proteomics services by creating multiple revenue-generating biomarker and target identification alliances with over 20 major pharmaceutical companies. In 2007, he led the spin-out, recapitalization, and sale of Caprion Proteomics to Great Point Partners, LLC, and in 2008 concluded Caprion's equity financing and strategic distribution alliance with Covance Inc., a leading global provider of drug development services. Prior to Caprion, LeBlanc worked as a management consultant with McKinsey & Company, as vice-president of sales and marketing (and later as general manager) at Advanced Bioconcept Ltd.
He is a member of the Board of Directors of Victhom Human Bionics (TSX: VHB), Mispro Pharma, Soricimed Pharmaceuticals, and Chairman of the Board of the Atlantic Cancer Research Institute, and he earned his bachelor's degree in economics from the University of Moncton prior to completing a master's in economics and politics at Oxford University as a Rhodes Scholar.
02.24.11 | 00:57:33 min
| 0 comments
03.30.10 | 01:17:01 min
| 1 comment